The Lung Institute’s Treatment Guidelines for Bronchiectasis Include Stem Cell Therapy

Bronchiectasis treatment guidelines are designed to help patients manage the symptoms of this chronic obstructive lung condition, which causes airway inflammation and breathing difficulties. Traditionally, the mainstay of bronchiectasis treatment has been antibiotic therapy used in conjunction with mucus-clearing devices. For some patients, this approach can effectively control the chronic bacterial infections that can result from excess mucus buildup. However, for very severe symptoms that do not respond to antibiotic treatment, lung surgery may be considered.

At the Lung Institute, our bronchiectasis treatment guidelines include stem cell therapy, an innovative, nonsurgical option. Our physicians have gained worldwide recognition for the successful application of innovative blood-based and bone-marrow based stem cell therapies in treating chronic lung conditions, including bronchiectasis. At our state-of-the-art facilities, we offer minimally invasive outpatient stem cell procedures designed to help our patients breathe easier and achieve a better quality of life.

Of course, our bronchiectasis treatment guidelines are highly individualized based on a number of unique factors. For instance, prior to recommending a specific treatment approach for a patient, we consider his or her answers to a number of questions, including:

  • When was he or she diagnosed with bronchiectasis?
  • What is the nature of his or her symptoms (i.e., severity of breathing difficulties, frequency of infections)?
  • Which medications has he or she tried to control the symptoms, and what were the results?
  • Does he or she use supplemental oxygen?
  • Does he or she smoke?
  • Does he or she have any other health concerns?

By harvesting stem cells that occur naturally within a patient’s own blood or bone marrow and reintroducing them intravenously, the Lung Institute offers an alternative therapy that provides a new source of hope for many patients who previously believed they were out of options. By taking advantage of the natural anti-inflammatory properties of stem cells, our treatments have shown significant progress in treating chronic pulmonary conditions with minimal side effects.

For more details on our bronchiectasis treatment guidelines and the potential effects of stem cell therapy on pulmonary function improvement, contact the Lung Institute today at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.